Skip to main content
Fig. 5 | BMC Pharmacology and Toxicology

Fig. 5

From: Immunomodulatory effects of detoxification agents on dendritic cell populations in methamphetamine addiction

Fig. 5

Mean fluorescence intensity (MFI) of the HLA-DR, CD11c, and CD123 molecules on the surface of peripheral blood dendritic cells. The level of HLA-DR molecule expression on the surface of dendritic cells (A) CD11c on the surface of CD11c + dendritic cells (B) and CD123 molecule on the surface of CD123 + dendritic cells (C) in the peripheral blood of Methamphetamine addicts during the detoxification period compared to the control group. DC = Dendritic cell, RisMeth = Methamphetamine addicts treated with Risperidone, RisMpMeth = Methamphetamine addicts treated with Risperidone and Methylphenidate, a = beginning of the trial, b = End of detoxification, c = no more than one month after detoxification. Data is presented as mean ± standard deviation. The results are obtained from the analysis of 100,000 mononuclear cells. The signs *(†) **(††) and ***(†††) indicate P < 0.05, P < 0.005, and P < 0.0005, respectively. The * sign for comparisons to the control, and the † sign denotes group comparisons

Back to article page